down arrow

Dolby Laboratories, Inc.

  • Market Cap: Small Cap
  • Industry: Software Products
  • ISIN: US25659T1079
USD
66.07
-0.22 (-0.33%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

65.9066.86

52 Week

64.0289.66
Valuation
Technical
Day's Volume

CASH

560.96 k

Shareholding (Mar 2025)

FII

13.36%

Held by 196 FIIs

DII

35.74%

Held by 58 DIIs

Promoter

0.01%

How big is Dolby Laboratories, Inc.?

22-Jun-2025

As of Jun 18, Dolby Laboratories, Inc. has a market capitalization of $7.11 billion, with net sales of $1.32 billion and net profit of $258.83 million over the latest four quarters. As of Sep 24, shareholder's funds are $2.48 billion and total assets are $3.13 billion.

As of Jun 18, Dolby Laboratories, Inc. has a market capitalization of 7,114.66 million, categorizing it as a Mid Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 1,320.19 million, while the sum of net profit for the same period is 258.83 million.<BR><BR>As of Sep 24, the reporting period shows shareholder's funds at 2,477.16 million and total assets at 3,130.61 million.

Read More

What does Dolby Laboratories, Inc. do?

22-Jun-2025

Dolby Laboratories, Inc. designs and manufactures audio and imaging products for the entertainment industry, with recent net sales of $370 million and a market cap of approximately $7.11 billion. Key financial metrics include a P/E ratio of 27.00 and a dividend yield of 1.73%.

Overview:<BR>Dolby Laboratories, Inc. designs and manufactures audio and imaging products for the cinema, television, broadcast, and entertainment industries, operating within the Software Products industry and classified as a mid-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 370 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 92 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 7,114.66 Million (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 27.00 <BR>Dividend Yield: 1.73% <BR>Debt Equity: -0.29 <BR>Return on Equity: 10.42% <BR>Price to Book: 2.76<BR><BR>Contact Details:<BR>Address: 1275 Market St, SAN FRANCISCO CA: 94103-1410 <BR>Tel: 1 415 5580200, 1 415 6455583 <BR>Fax: 1 415 6454000 <BR>Website: https://www.dolby.com/

Read More

Who are in the management team of Dolby Laboratories, Inc.?

22-Jun-2025

As of March 2022, the management team of Dolby Laboratories, Inc. includes CEO Kevin Yeaman and several independent directors, including Peter Gotcher (Chairman), Micheline Chau, David Dolby, N. William Jasper, Simon Segars, and Roger Siboni.

As of March 2022, the management team of Dolby Laboratories, Inc. includes the following individuals:<BR><BR>- Mr. Peter Gotcher, who serves as the Independent Chairman of the Board.<BR>- Mr. Kevin Yeaman, who is the President, Chief Executive Officer, and a Director.<BR>- Ms. Micheline Chau, who is an Independent Director.<BR>- Mr. David Dolby, who is also an Independent Director.<BR>- Mr. N. William Jasper, serving as an Independent Director.<BR>- Mr. Simon Segars, who is an Independent Director.<BR>- Mr. Roger Siboni, who is another Independent Director.<BR><BR>In summary, the management team features a mix of independent directors and key executives, with Mr. Kevin Yeaman as the CEO.

Read More

Is Dolby Laboratories, Inc. technically bullish or bearish?

23-Sep-2025

As of September 19, 2025, Dolby Laboratories, Inc. is in a bearish trend with moderate strength, indicated by bearish MACD and moving averages, while underperforming the S&P 500 with year-to-date and one-year returns of -7.32% and -1.20%, respectively.

As of 19 September 2025, the technical trend for Dolby Laboratories, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength indicated by the weekly MACD and moving averages both showing bearish signals. The weekly RSI is bullish, but the overall trend remains negative due to the bearish MACD and daily moving averages. Additionally, the Bollinger Bands and OBV are also indicating a mildly bearish trend. <BR><BR>In terms of performance, Dolby's returns are underperforming the S&P 500 across multiple periods: it has a year-to-date return of -7.32% compared to the S&P 500's 13.31%, and a one-year return of -1.20% versus the S&P 500's 16.64%.

Read More

Is Dolby Laboratories, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Dolby Laboratories, Inc. is considered attractive but overvalued, with a P/E ratio of 27 compared to the peer average of 25.89, and a year-to-date return of -11.97%, underperforming the S&P 500's 13.30%.

As of 17 October 2025, the valuation grade for Dolby Laboratories, Inc. has moved from very attractive to attractive. The company appears to be overvalued based on its current metrics. The P/E ratio stands at 27, which is significantly higher than its peer average of approximately 25.89. Additionally, the EV to EBITDA ratio of 17.08 also exceeds the peer average of 16.20, while the PEG ratio of 2.73 indicates that the stock may be overvalued relative to its growth prospects.<BR><BR>In comparison to its peers, Dolby's valuation ratios suggest a premium position, especially when juxtaposed with Duolingo, Inc., which has a P/E of 104.90, and Qualys, Inc., with a P/E of 25.97. The stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -11.97% compared to the index's 13.30%, reinforcing the notion that Dolby may be overvalued in the current market environment.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company has a low Debt to Equity ratio (avg) at times

 
2

Poor long term growth as Net Sales has grown by an annual rate of 2.52% and Operating profit at 3.12% over the last 5 years

 
3

Flat results in Jun 25

4

With ROE of 10.42%, it has a attractive valuation with a 2.80 Price to Book Value

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Software Products

stock-summary
Market cap

USD 7,024 Million (Small Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.80%

stock-summary
Debt Equity

-0.29

stock-summary
Return on Equity

10.42%

stock-summary
Price to Book

2.70

Revenue and Profits:
Net Sales:
316 Million
(Quarterly Results - Jun 2025)
Net Profit:
47 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.23%
0%
-9.23%
6 Months
-12.19%
0%
-12.19%
1 Year
-17.89%
0%
-17.89%
2 Years
-24.81%
0%
-24.81%
3 Years
-13.25%
0%
-13.25%
4 Years
-23.84%
0%
-23.84%
5 Years
-27.74%
0%
-27.74%

Dolby Laboratories, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Dolby Laboratories Stock Plummets to New 52-Week Low at $64.23

Dolby Laboratories Stock Plummets to New 52-Week Low at $64.23

Dolby Laboratories, Inc. has hit a new 52-week low, reflecting an 18.4% decline in stock price over the past year. The company faces financial challenges, including decreased profits and stagnant growth, while its market capitalization is approximately USD 7 billion. Institutional holdings remain high at 100%.

Read More
Dolby Laboratories Stock Plummets to New 52-Week Low at $64.38

Dolby Laboratories Stock Plummets to New 52-Week Low at $64.38

Dolby Laboratories, Inc. has reached a 52-week low, trading at USD 64.38 as of November 7, 2025, following a 17.7% decline in stock price over the past year. The company faces challenges with declining profits and flat sales growth, despite strong institutional interest and a notable market capitalization.

Read More
Dolby Laboratories Stock Hits 52-Week Low at $64.50

Dolby Laboratories Stock Hits 52-Week Low at $64.50

Dolby Laboratories, Inc. has hit a new 52-week low, trading at USD 64.50 as of October 30, 2025. The company has experienced a 17% decline in stock price over the past year, with recent financial results showing significant decreases in pre-tax and net profits, alongside flat sales growth.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.52%
EBIT Growth (5y)
3.12%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
0.53
Tax Ratio
18.15%
Dividend Payout Ratio
44.61%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
17.26%
ROE (avg)
10.34%
Valuation key factors
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
2.80
EV to EBIT
22.83
EV to EBITDA
17.08
EV to Capital Employed
3.52
EV to Sales
4.89
PEG Ratio
2.73
Dividend Yield
1.71%
ROCE (Latest)
15.43%
ROE (Latest)
10.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 102 Schemes (50.84%)

Foreign Institutions

Held by 196 Foreign Institutions (13.36%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -14.64% vs 3.53% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -49.57% vs 35.39% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "315.50",
          "val2": "369.60",
          "chgp": "-14.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "71.50",
          "val2": "136.40",
          "chgp": "-47.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.50",
          "val2": "-4.20",
          "chgp": "111.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "46.50",
          "val2": "92.20",
          "chgp": "-49.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "149.20%",
          "val2": "303.00%",
          "chgp": "-15.38%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2024 is -2.00% vs 3.66% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2024 is 31.10% vs 9.62% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,273.70",
          "val2": "1,299.70",
          "chgp": "-2.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "352.00",
          "val2": "358.30",
          "chgp": "-1.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.40",
          "val2": "-47.10",
          "chgp": "86.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "264.30",
          "val2": "201.60",
          "chgp": "31.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "207.80%",
          "val2": "202.20%",
          "chgp": "0.56%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
315.50
369.60
-14.64%
Operating Profit (PBDIT) excl Other Income
71.50
136.40
-47.58%
Interest
0.00
0.00
Exceptional Items
0.50
-4.20
111.90%
Consolidate Net Profit
46.50
92.20
-49.57%
Operating Profit Margin (Excl OI)
149.20%
303.00%
-15.38%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -14.64% vs 3.53% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -49.57% vs 35.39% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,273.70
1,299.70
-2.00%
Operating Profit (PBDIT) excl Other Income
352.00
358.30
-1.76%
Interest
0.00
0.00
Exceptional Items
-6.40
-47.10
86.41%
Consolidate Net Profit
264.30
201.60
31.10%
Operating Profit Margin (Excl OI)
207.80%
202.20%
0.56%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Sep 2024 is -2.00% vs 3.66% in Sep 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Sep 2024 is 31.10% vs 9.62% in Sep 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Dolby Laboratories, Inc. stock-summary
stock-summary
Dolby Laboratories, Inc.
Software Products
Dolby Laboratories, Inc. designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration. Its technologies include Advanced Audio Coding and High Efficiency Advanced Audio Coding, Dolby AC-4, Dolby Atmos, Dolby Digital, Dolby Digital Plus, Dolby TrueHD, Dolby Vision, Dolby Voice and High Efficiency Video Coding. It distributes its products in over 80 countries. Its technologies are incorporated in offerings in various end markets, such as the broadcast, Personal Computer, mobile, consumer electronics and other markets.
Company Coordinates stock-summary
Company Details
1275 Market St , SAN FRANCISCO CA : 94103-1410
stock-summary
Tel: 1 415 55802001 415 6455583
stock-summary
https://www.dolby.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."